LEADER 02285nam  2200553 a 450 
001 9910456135403321
005 20200520144314.0
010   $a1-4619-3812-0
010   $a1-58528-338-X
035   $a(CKB)2480000000007027
035   $a(OCoLC)609402328
035   $a(CaPaEBR)ebrary10739964
035   $a(SSID)ssj0000332360
035   $a(PQKBManifestationID)11232200
035   $a(PQKBTitleCode)TC0000332360
035   $a(PQKBWorkID)10334153
035   $a(PQKB)11006355
035   $a(MiAaPQ)EBC3115739
035   $a(Au-PeEL)EBL3115739
035   $a(CaPaEBR)ebr10739964
035   $a(OCoLC)922966269
035   $a(EXLCZ)992480000000007027
100   $a20091015d2010      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aConcepts in clinical pharmacokinetics$b[electronic resource] /$fJoseph T. DiPiro ... [et al.]
205   $a5th ed.
210   $aBethesda, Md. $cAmerican Society of Health-System Pharmacists$dc2010
215   $a1 online resource (260 p.)
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a1-58528-241-3 
320   $aIncludes bibliographical references and index.
327   $aIntroduction to pharmacokinetics and pharmacodynamics -- Basic pharmacokinetics -- Half-life, elimination rate, and AUC -- Intravenous bolus administration, multiple drug administration, and steady-state average concentrations -- Relationships of pharmacokinetic parameters and intravenous intermittent and continuous infusions -- Two-compartment models -- Biopharmaceutics : absorption -- Drug distribution and protein binding -- Drug elimination processes -- Nonlinear processes -- Pharmacokinetic variation and model-independent relationships -- Aminoglycosides -- Vancomycin -- Theophylline -- Phenytoin and digoxin.
606   $aPharmacokinetics
608   $aElectronic books.
615  0$aPharmacokinetics.
676   $a615/.7
701   $aDiPiro$b Joseph T$0292649
712 02$aAmerican Society of Health-System Pharmacists.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910456135403321
996   $aConcepts in clinical pharmacokinetics$92112488
997   $aUNINA